BN Business News
Unternehmen hinzufügen →
Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.

Geschäft · 18.6.20031 Min. Lesezeit

Safety Reporting Requirements for Human Drug and Biological Products; Extension of Comment Period

Lokale automatische Übersetzung · Originalsprache der Quelle

Zusammenfassung

The Food and Drug Administration (FDA) is extending to October 14, 2003, the comment period for a proposed rule published in the Federal Register of March 14, 2003 (68 FR 12406). The proposed rule would amend the agency's pre- and postmarketing safety reporting regulations for human drug and biological products. The agency is taking this action in response to a request for more time to submit comments to FDA.

Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →

Weitere Themen

Business-Analysen →